These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


216 related items for PubMed ID: 35771357

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Upregulated circular RNA circ_0007534 indicates an unfavorable prognosis in pancreatic ductal adenocarcinoma and regulates cell proliferation, apoptosis, and invasion by sponging miR-625 and miR-892b.
    Hao L, Rong W, Bai L, Cui H, Zhang S, Li Y, Chen D, Meng X.
    J Cell Biochem; 2019 Mar; 120(3):3780-3789. PubMed ID: 30382592
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Circ_0072008, an oncogene in pancreatic ductal adenocarcinoma, contributes to tumour cell malignant progression and glycolysis by regulating miR-545-3p/SLC7A11 axis.
    Sun H, Liu F, Zhang H.
    Autoimmunity; 2022 May; 55(3):203-213. PubMed ID: 35166634
    [Abstract] [Full Text] [Related]

  • 9. Circ-ASH2L promotes tumor progression by sponging miR-34a to regulate Notch1 in pancreatic ductal adenocarcinoma.
    Chen Y, Li Z, Zhang M, Wang B, Ye J, Zhang Y, Tang D, Ma D, Jin W, Li X, Wang S.
    J Exp Clin Cancer Res; 2019 Nov 12; 38(1):466. PubMed ID: 31718694
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Upregulated circular RNA circ_0030235 predicts unfavorable prognosis in pancreatic ductal adenocarcinoma and facilitates cell progression by sponging miR-1253 and miR-1294.
    Xu Y, Yao Y, Gao P, Cui Y.
    Biochem Biophys Res Commun; 2019 Jan 29; 509(1):138-142. PubMed ID: 30591218
    [Abstract] [Full Text] [Related]

  • 12. Circular RNA circ-MTHFD1L induces HR repair to promote gemcitabine resistance via the miR-615-3p/RPN6 axis in pancreatic ductal adenocarcinoma.
    Chen ZW, Hu JF, Wang ZW, Liao CY, Kang FP, Lin CF, Huang Y, Huang L, Tian YF, Chen S.
    J Exp Clin Cancer Res; 2022 Apr 23; 41(1):153. PubMed ID: 35459186
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The promoting effects of hsa_circ_0050102 in pancreatic cancer and the molecular mechanism by targeting miR-1182/NPSR1.
    Hua S, Gao J, Li T, Wang M, You L, Chen G, Han X, Liao Q.
    Carcinogenesis; 2021 Apr 17; 42(3):471-480. PubMed ID: 33289016
    [Abstract] [Full Text] [Related]

  • 16. Suppression of Circular RNA Hsa_circ_0109320 Attenuates Non-Small Cell Lung Cancer Progression via MiR-595/E2F7 Axis.
    Bai Q, Li L, Chen F, Zhu J, Cao L, Yang Y, Zhong F.
    Med Sci Monit; 2020 Jun 08; 26():e921200. PubMed ID: 32508344
    [Abstract] [Full Text] [Related]

  • 17. Tumor-released exosomal circular RNA PDE8A promotes invasive growth via the miR-338/MACC1/MET pathway in pancreatic cancer.
    Li Z, Yanfang W, Li J, Jiang P, Peng T, Chen K, Zhao X, Zhang Y, Zhen P, Zhu J, Li X.
    Cancer Lett; 2018 Sep 28; 432():237-250. PubMed ID: 29709702
    [Abstract] [Full Text] [Related]

  • 18. FUS-induced circRHOBTB3 facilitates cell proliferation via miR-600/NACC1 mediated autophagy response in pancreatic ductal adenocarcinoma.
    Yang T, Shen P, Chen Q, Wu P, Yuan H, Ge W, Meng L, Huang X, Fu Y, Zhang Y, Hu W, Miao Y, Lu Z, Jiang K.
    J Exp Clin Cancer Res; 2021 Aug 20; 40(1):261. PubMed ID: 34416910
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. hsa_circ_0007919 induces LIG1 transcription by binding to FOXA1/TET1 to enhance the DNA damage response and promote gemcitabine resistance in pancreatic ductal adenocarcinoma.
    Xu L, Ma X, Zhang X, Zhang C, Zhang Y, Gong S, Wu N, Zhang P, Feng X, Guo J, Zhao M, Ren Z, Zhang P.
    Mol Cancer; 2023 Dec 04; 22(1):195. PubMed ID: 38044421
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.